In recent years, studies on familial hypercholesterolemia have focused on low-density lipoprotein receptor, apolipoprotein B and proprotein convertase subtilisin/kexin type 9 (PCSK9). The gene discussed is PCSK9; the disease is familial hypercholesterolemia.